Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Welcome first child
Murder suspect beaten
Calls for suspension
William J. O’Neil dies
Man survives attack
Fiery gasoline assault
Domestic abuse case
BRICS-meeting immunity
Jordan royal wedding
Middle Ages roofwork
Fungal meningitis
Panic buying fuel
Home-schooled rebels
JP same-sex marriage
Poses extinction risk?
RU gender change bill
Uganda human organ law
Denmark defense budget
Mafia suspects nabbed
Musk meets Qin Gang
Kenya cholera crisis
Aussie volcano erupts
China mosque clashes
Strike a deal
Off to space station
Clash kills 17
Greece cyberattack
Congo civilians killed
Criticize Polish plans
ChatGPT’s reading list
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
14,600 results
7don MSN
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
WTVF28d
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
Yahoo News7d
US FDA approves Opiant's spray for reversing opioid-related overdoses
The approval comes nearly two months after the U.S. health regulator approved the prescription-free sale of Emergent Biosolutions' Narcan nasal spray, which is a naloxone-based drug used to reverse ...
drugdeliverybusiness7d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Medscape4d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.
Seeking Alpha19d
Emergent BioSolutions: A Turnaround In Sight With OTC Narcan Amidst Ongoing Opioid Crisis
The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...
Riverfront Times24d
St. Louis Man Made a Narcan Dispenser. He Hopes You Do, Too
He hopes other people will be inspired to set up boxes in their own neighborhoods. Related FDA Approves Narcan for Over-the-Counter Use: The medication, which rapidly reverses overdoses ...
7d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
FOX 10 Phoenix
7d
FDA approves new nasal spray to reverse fentanyl, other opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
EMS1
7d
FDA approves new nasal spray to reverse fentanyl, opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Too Old to Operate
6d
FDA Approves New Nasal Spray to Reverse Overdoses
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...
High Times
6d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics

opioid overdose
Opvee
Food and Drug Administration
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback